attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Give me imp points from these pages so i dont have to study from them

Here are the important points from all 10 pages (pp. 273-282) on the Thyroid Gland:

🫁 THYROID GLAND - High-Yield Notes (pp. 273-282)


SURGICAL ANATOMY

  • Located in anterior triangle of neck, enclosed by pre-tracheal fascia (part of deep cervical fascia)
  • Weight: 20-25g; two lobes joined by isthmus (in front of 2nd, 3rd & 4th tracheal rings)
  • Projection from isthmus on left side = pyramidal lobe
Blood Supply:
  • Superior thyroid artery - branch of external carotid artery
  • Inferior thyroid artery - branch of thyrocervical trunk
  • Thyroid ima artery - branch of brachiocephalic trunk or aorta (2-3% cases)
Venous Drainage:
  • Superior & middle thyroid veins β†’ internal jugular vein
  • Inferior thyroid veins β†’ anastomose with each other β†’ brachiocephalic vein
Lymphatics: β†’ deep cervical lymph nodes
Important Nerves:
  1. Recurrent laryngeal nerve - runs in tracheoesophageal groove; supplies all laryngeal muscles EXCEPT cricothyroid; major nerve supply to vocal cords - must be protected during thyroidectomy
  2. External laryngeal nerve - branch of superior laryngeal nerve; runs close to superior thyroid vessels; supplies cricothyroid muscle (adductors of vocal cords)
Histology: Follicles lined by cuboidal epithelium (thyrocytes); C-cells (parafollicular) produce Calcitonin - tumor marker for medullary carcinoma

THYROID HORMONE SYNTHESIS (5 Steps)

  1. Trapping - Iodides absorbed into follicular cells by iodide pump
  2. Oxidation - Iodides β†’ iodine by peroxidase enzyme
  3. Binding - Iodine + tyrosine β†’ monoiodotyrosine
  4. Coupling - monoiodotyrosine + di-iodotyrosine β†’ T3 & T4
  5. Secretion - T3 & T4 released into plasma; bind to TBG & TBPA; only 0.03% of T4 and 0.3% of T3 exist in free (biologically active) form. TSH from anterior pituitary (regulated by hypothalamic TRH) controls synthesis.

INVESTIGATIONS OF THYROID DISEASE

TestKey Point
TSH (normal 0.3-3.3 mU/L)↓ in thyrotoxicosis; ↑ in hypothyroidism
T3 & T4Free levels reflect functional status
Thyroid antibodiesTPO & antithyroglobulin ↑ in Hashimoto's; TRAbs ↑ in Graves'
UltrasoundDifferentiates solid from cystic; identifies parathyroid adenoma
CT scanOnly for suspected malignancy (staging)
Isotope scan (⁹⁹mTc)Hot=hyperfunctioning; Cold=non-functioning; Warm=normal
FNACInvestigation of choice for discrete/solitary swelling; CANNOT differentiate follicular adenoma from follicular carcinoma (needs excisional biopsy for capsular/vascular invasion)
X-ray chestDetect retrosternal extension, tracheal compression, deviation, pulmonary metastasis
Thyroid Function Interpretation:
  • Euthyroid: T3, T4, TSH all normal
  • Thyrotoxicosis: ↓TSH, ↑T3, ↑T4
  • Hypothyroidism: ↑TSH, ↓T3, ↓T4
  • T3 toxicity: ↓/normal TSH, ↑T3, normal T4

THYROGLOSSAL DUCT CYST

  • Thyroid arises from primitive foregut at 3rd week of gestation at foramen of cecum
  • Descends to neck with isthmus over 2nd & 3rd tracheal ring
  • Connected via epithelial-lined thyroglossal duct (obliterates by 8th week)
  • Cyst can occur anywhere along migratory path; 80% near hyoid bone
  • May be the ONLY functional thyroid tissue - do thyroid scan before excision
Clinical features: Midline swelling; moves up with swallowing AND with tongue protrusion (unlike thyroid which moves only with swallowing)
Treatment: Sistrunk operation - excision of whole thyroglossal duct tract including body of hyoid bone up to base of tongue
Thyroglossal Fistula: Usually follows infection/incomplete excision β†’ treated by Sistrunk operation

LINGUAL THYROID

  • Failure of median thyroid anlage to descend normally; may be the only thyroid tissue
  • Symptoms: choking, dysphagia, airway obstruction, hemorrhage
  • Treatment: exogenous thyroid hormone + RAI ablation; surgical excision rarely needed (must confirm normal thyroid tissue elsewhere first)

GOITRE CLASSIFICATION

TypeExamples
Simple (Euthyroid)Diffuse, Multinodular
Toxic (Hyperthyroid)Graves', Toxic MNG, Toxic adenoma
HypothyroidUsually Multinodular
NeoplasticBenign, Malignant
InflammatoryHashimoto's, De Quervain's, Bacterial/Viral, Riedel's

SIMPLE GOITRE (EUTHYROID)

  • Enlargement WITHOUT hypo/hyper functioning; diffuse or multinodular
  • Pathogenesis: ↑TSH β†’ hypertrophy + hyperplasia of follicles
  • Causes: Iodine deficiency, Dyshormogenesis, Goitrogens (cabbage/kale/rape - contain thiocyanates), ↑demand (puberty, pregnancy)
  • Nodule formation: Some follicles are more sensitive to TSH β†’ enlarge more β†’ nodules
Treatment: Thyroxine 100-200mcg/day; nodular stage is irreversible Indications for thyroidectomy: Pressure effects (dysphagia/dyspnea), retrosternal goitre, cosmetic, patient anxiety
  • Total thyroidectomy: All tissue removed; lifelong thyroxine 150mcg/day
  • Subtotal thyroidectomy: 8g left on each side; parathyroids preserved; less RLN injury risk BUT remnant may regrow

HYPERTHYROIDISM / THYROTOXICOSIS

  • Hyperthyroidism = overproduction by thyroid gland (demonstrable on scan)
  • Thyrotoxicosis = biochemical + physiological manifestations of excess thyroid hormone (broader term)
Common causes:
  • Diffuse toxic (Graves') - 70%
  • Toxic MNG
  • Toxic adenoma (Plummer's disease)

Graves' Disease (Diffuse Toxic Goitre)

  • Autoimmune; caused by TSH-RAb (IgG antibodies) binding TSH receptors β†’ ↑T3, T4
  • Primary thyrotoxicosis - simultaneous goitre + thyrotoxicosis + eye signs (more pronounced)

Toxic MNG (Secondary Thyrotoxicosis)

  • In older patients; prior history of non-toxic MNG
  • Nodules become autonomous; rarely associated with eye signs

Toxic Adenoma (Plummer's Disease)

  • Younger patients; single hyperfunctioning nodule; caused by somatic mutation in TSH receptor

Thyrotoxicosis Factitia

  • Exogenous over-administration of thyroxine

Jod-Basedow

  • Large dose iodide given to patient with hyperplastic endemic goitre

CLINICAL FEATURES OF THYROTOXICOSIS

Symptoms: Palpitation, heat intolerance, weight loss with good appetite, increased appetite, insomnia, restlessness, diarrhoea, menstrual irregularities
Signs: Tachycardia, hot moist palm, exophthalmos, lid lag/retraction, exaggerated reflexes, thyroid bruit, pretibial myxedema, cardiac arrhythmias, fine resting tremors, thyroid acropathy, onycholysis

EYE SIGNS (Graves' Ophthalmopathy) - occur in 50% of Graves' patients

SignDescription
Lid Retraction (Dalrymple's sign)Upper lid raised, lower lid at normal position - due to overactivity of levator palpebrae superioris (sympathetic)
Lid Lag (Von Graefe's sign)Upper eyelid lags behind eyeball on looking down
Stellwag's signInfrequent/incomplete blinking
Naffziger's signStand behind patient, tilt head back - can see eyeball from above (severe exophthalmos)
Joffroy's signAbsence of forehead wrinkling when looking upward (eye ball forward)
Moebius signInability to converge eyeball (no space in orbit for movement)
ExophthalmosBulging of eye due to retro-orbital cellular infiltration
OphthalmoplegiaParalysis of lateral rectus & inferior oblique most commonly
Pretibial Myxedema: Thickening of skin around pretibial region + dorsum of foot; caused by TSH-RAb mediated process (NOT same as myxedema of hypothyroidism)

TREATMENT OF THYROTOXICOSIS

A. Antithyroid Drugs (Carbimazole, Propylthiouracil)

  • Interfere with oxidation of iodides + binding of iodine to tyrosine
  • Beta blockers (propranolol) block cardiovascular effects
  • Dose: Carbimazole 10mg TDS initially β†’ 5mg TDS or BD for 6-24 months
  • Side effect: Agranulocytosis or aplastic anaemia (very dangerous)
  • Failure rate: 50%; treatment duration 6-24 months
  • Block & Replace therapy: High dose carbimazole + thyroxine 100-150mcg/day
  • In pregnancy: Use propylthiouracil (carbimazole crosses placenta β†’ fetal hypothyroidism)

B. Surgery (Subtotal/Total Thyroidectomy)

  • Patient MUST be made euthyroid before surgery
  • Drug of choice for preparation: Carbimazole 30-40mg; when euthyroid (8-12 weeks) reduce to 5mg 8-hourly
  • Beta blockers can be used alternatively (inhibit peripheral T4β†’T3 conversion); propranolol 40mg TDS
  • Advantages: Rapid, high cure rate
  • Disadvantages: Risk of hypoparathyroidism (5%), RLN injury, 5% recurrence with subtotal
Which surgery is preferred?
  • Young patients: Total thyroidectomy (avoids late recurrence)
  • Old patients: Subtotal thyroidectomy (takes 10-15 years to develop recurrence)
  • Post-subtotal: lifelong thyroxine 200mcg/day (suppressive dose) to prevent recurrence + prevent hypothyroidism

C. Radioactive Iodine (RAI)

  • Beta & gamma rays from radioactive iodine destroy thyroid follicles
  • Advantages: No surgery, no prolonged drug treatment
  • Disadvantages: Late hypothyroidism
  • Contraindications: Absolute - pregnancy & breastfeeding; Relative - young patients, multinodularity, Graves' ophthalmopathy

Treatment Choice by Case:

CasePreferred Treatment
Graves' >45 yearsRadioiodine
Graves' <45 yearsSurgery (1st choice for large goitre)
Toxic MNGSurgery
Toxic AdenomaSurgery (lobectomy); RAI if >45 years
PregnancySurgery/antithyroid drugs (2nd trimester); RAI contraindicated
ChildrenRAI contraindicated
ThyrocardiacRAI + antithyroid drugs for 6 weeks
ProptosisAntithyroid drugs/surgery (avoid RAI until stable 6 months)
Recurrence after surgeryRAI or antithyroid drugs

HYPOTHYROIDISM

Infantile Hypothyroidism (Cretinism)

  • Inadequate thyroid hormone during fetal/neonatal life
  • Endemic (iodine deficiency) or sporadic (congenital enzyme deficiency / thyroid agenesis)
  • Features: hoarse cry, macroglossia, umbilical hernia
  • Treatment with thyroxine lessens neurological/intellectual deficits

Adult Hypothyroidism

Primary (↑TSH, ↓T3, ↓T4): Iodine deficiency, post-thyroidectomy, post-RAI, antithyroid drugs, Hashimoto's, dyshormogenesis, thyroid agenesis Secondary (↓TSH): Pituitary tumor/resection Tertiary: Hypothalamic insufficiency
Symptoms: Fatigue, lethargy, cold intolerance, weight gain, constipation, dry skin, loss of hair from lateral 1/3 of eyebrow, memory problems, hoarseness of voice
Signs: Bradycardia, cold extremity, peri-orbital puffiness, brady kinesis, Woltman's sign (delayed relaxation phase of ankle jerk reflex - most easily elicited at Achilles/patellar/biceps tendon)
Diagnosis: ↓T3, T4 | ↑TSH (except secondary/tertiary) | ↑TPO antibodies = autoimmune disease Treatment: Oral thyroxine 150mcg as single daily dose; if rapid response needed - T3 (20mcg TDS)

MYXOEDEMA & MYXOEDEMA COMA

  • Myxoedema: Exaggerated symptoms of hypothyroidism
  • Myxoedema Coma: Most severe form; mortality 30-60%; seen in known hypothyroid patients exposed to stress (surgery, trauma, cold, pneumonia, CVA, sedatives, anesthesia)
  • Features: Hypothermia, altered consciousness, delirium, respiratory failure, cardiac dysfunction
  • Treatment: IV thyroxine 500mcg bolus T4 or 10mcg T3 IV; warm slowly; IV hydrocortisone; IV antibiotics (mortality is HIGH)

DISCRETE THYROID NODULE

  • Affects 4-7% of population; solitary vs. dominant
  • Solitary: Single swelling in otherwise impalpable gland (15-20% malignant!)
  • Dominant: Single obvious swelling with mild background nodularity
  • 70% of discrete swellings are solitary; 30% dominant
  • Thyroid scan: Hot (overactive), Warm (normal), Cold (non-active/suspicious)
  • FNAC = investigation of choice

PENDRED'S SYNDROME

  • Form of dyshormogenesis with deficiency of TPO (thyroid peroxidase oxidase)
  • Associated with hypothyroidism + sensorineural hearing impairment (abnormality of bony labyrinth)

Key mnemonics to remember:
  • Sistrunk = treatment for thyroglossal duct cyst/fistula
  • FNAC cannot differentiate follicular adenoma from carcinoma (needs excision for capsular/vascular invasion)
  • Carbimazole crosses placenta β†’ use PTU in pregnancy
  • Woltman's sign = delayed ankle jerk = hypothyroidism
  • Calcitonin = tumor marker for medullary carcinoma (from C-cells)
  • Graves' eye signs = PRIMARY thyrotoxicosis; Toxic MNG = SECONDARY (rarely eye signs)
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Give me important points from these pages so i dont have to study them

Here are all the important points from pages 282-293 (Thyroid continued + Parathyroid Glands):

🫁 THYROID GLAND - Continued (pp. 282-290)


DISCRETE THYROID NODULE - FNAC

FNAC can diagnose:
  • Colloid nodule, Medullary carcinoma, Thyroiditis, Papillary carcinoma, Lymphoma
FNAC CANNOT distinguish benign follicular adenoma from follicular carcinoma (needs capsular/vascular invasion assessment - only on excisional biopsy)
Core biopsy - indicated when FNAC is non-conclusive
Differential diagnosis of discrete thyroid swelling: Toxic adenoma, Non-toxic solitary nodule, Follicular adenoma, Follicular carcinoma, Thyroid cyst, Thyroglossal cyst, Lymph node
Indications for operation (solitary/dominant nodule):
  • FNAC positive for malignancy
  • Age <20 or >50 years
  • Male sex
  • Hard and fixed
  • Recurrent laryngeal nerve palsy
  • Lymphadenopathy
  • Recurrent cyst
  • Toxic adenoma
  • Pressure symptoms / Cosmesis
Treatment of solitary thyroid nodule = Lobectomy

RETROSTERNAL GOITRE

  • Most due to enlargement of lower pole of nodular goitre; common in short neck males
  • Clinical features: Dysphagia, dyspnea (may attend as asthma at night), engorgement of neck and chest wall veins on raising arm above head = Pemberton's sign
  • Diagnosis: X-ray chest thoracic inlet (soft tissue shadow in superior mediastinum); CT scan is most accurate

THYROID CARCINOMA

Overview of Types:

TypeKey Facts
PapillaryMost common DTC; multifocal & bilateral (30%); spreads to local lymph nodes; does NOT take up RAI (only 5%); higher mortality
FollicularDTC; spreads hematogenously; takes up RAI
MedullaryTumor of parafollicular (C) cells from neural crest; NOT from follicles
AnaplasticMost aggressive; poor prognosis
LymphomaFollows autoimmune thyroiditis (Hashimoto's)

Treatment of DTC (Papillary & Follicular):

  • Surgery + Radioiodine therapy
  • Total thyroidectomy performed; if cervical lymph nodes involved β†’ neck dissection also
  • Post-op: thyroxine therapy avoided for 3 weeks β†’ TSH rises β†’ whole body RAI scan performed to detect residual/metastatic disease
  • For whole body scan: All normal thyroid tissue must be ablated first (otherwise normal tissue competes with cancer for RAI uptake)
  • If residual/metastatic disease found β†’ treat with RAI

Post-op Treatment & Follow up of DTC:

  1. Thyroxine 200mcg/day - replacement + suppress TSH (TSH thought to cause carcinoma recurrence)
  2. Follow up with thyroglobulin level - initially 6-monthly then yearly; if raised β†’ whole body thyroid scan

Whole Body Thyroid Scan Prerequisites:

  • T4 therapy stopped 6 weeks before scan (allows TSH to rise by reflex)
  • OR synthetic recombinant TSH given 48 hours before scan
  • T3 therapy should be discontinued 2 weeks before scan (shorter half-life than T4)

Medullary Thyroid Carcinoma (MTC):

  • Tumor of parafollicular cells derived from neural crest cells (NOT follicles)
  • Markers: Calcitonin + Carcinoembryonic antigen (CEA) - raised level after resection = recurrence
  • 25% occur in inherited syndromes: Familial MTC, MEN2A, MEN2B - all due to RET proto-oncogene mutation
  • Familial form: children & young adults; Sporadic: any age
Treatment of MTC:
  • Total thyroidectomy + bilateral central lymph node dissection (medial to carotid sheath) - frequently involved (50-66%) early in disease
  • Large tumor (>1cm) or positive central LN β†’ modified radical neck dissection
  • No role of radioactive iodine, No chemotherapy
  • Follow up with calcitonin + CEA; recurrence treated by RAI/lifelong thyroxine
MTC in MEN-2A: Associated with phaeochromocytoma + hyperparathyroidism
  • Rule out phaeochromocytoma by measuring urinary catecholamines BEFORE thyroidectomy
  • If phaeochromocytoma found β†’ operate on phaeochromocytoma FIRST
  • Prophylactic thyroidectomy indicated in RET mutation carriers:
    • MEN2B: before 1 year of age
    • MEN2A: before 6 years of age
MEN2A with hypercalcemia at thyroidectomy: Only obviously enlarged parathyroids removed; others preserved; if normal parathyroid cannot be maintained on vascular pedicle β†’ remove, biopsy, autotransplant to forearm of non-dominant arm

Anaplastic Carcinoma:

  • Most aggressive; all treatments have disappointing outcomes; survival <6 months
  • If confined to thyroid (rare) β†’ total thyroidectomy
  • External beam radiotherapy has some role
  • Tracheal obstruction β†’ isthmusectomy to relieve tracheal compression

Lymphoma of Thyroid:

  • Follows Hashimoto's thyroiditis (autoimmune)
  • Stage I & II β†’ Radiotherapy
  • Stage III & IV β†’ Chemotherapy (CHOP)

Summary - Treatment of Thyroid Carcinoma:

TypeTreatment
Differentiated (Papillary/Follicular)Total thyroidectomy + radioablation; follow up with thyroglobulin + whole body scan
MedullaryTotal thyroidectomy + neck node dissection; follow up calcitonin + CEA; no RAI
AnaplasticSymptomatic; isthmusectomy for tracheal compression; external beam radiotherapy
Lymphoma Stage I/IIRadiotherapy
Lymphoma Stage III/IVChemotherapy

TYPES OF THYROID SURGERY

OperationWhat is removed
Total thyroidectomyBoth lobes + isthmus
Subtotal thyroidectomy8g (4x4cm) of thyroid tissue preserved on each side
Near total thyroidectomy8g preserved on one side + total lobectomy on other side (Hartley-Dunhill procedure)
LobectomyOne lobe + isthmus

PRE-OPERATIVE PREPARATION FOR THYROID SURGERY

  • Patient MUST be euthyroid before surgery
  • Carbimazole 10mg TDS β†’ reduce to 5mg TDS when euthyroid (8-12 weeks)
  • Propranolol 40mg TDS - blocks peripheral T4β†’T3 conversion + blocks peripheral effects
  • Iodine (Lugol's) - given for 10 days before surgery to reduce vascularity of gland
  • In pregnancy: Use propylthiouracil (not carbimazole - crosses placenta)

STEPS OF THYROIDECTOMY (pp. 288-289)

  1. General anesthesia; neck extended; head side of table elevated
  2. Collar incision (Kocher's incision): Transverse 4-5cm incision, 2cm above suprasternal notch
  3. Subcutaneous tissue + platysma incised; subplatysmal flaps raised up to thyroid cartilage, down to suprasternal notch
  4. Incise median raphe + mobilize strap muscles (retract laterally if small goitre; divide if large goitre)
  5. Retract thyroid medially β†’ identify + ligate middle thyroid vein (RLN is posterior to this vein - beware!)
  6. Identify + mobilize superior pole β†’ ligate superior thyroid artery & vein close to thyroid (to avoid damage to external laryngeal nerve)
  7. Ligate inferior pole vessels (inferior thyroid vein + artery separately) medial→lateral; identify RLN (always close to inferior pole vessels)
  8. Divide Berry's ligament + mobilize thyroid from trachea
  9. For lobectomy: isthmus divided flush with trachea on contralateral side + suture ligated
  10. Hemostasis; suction drain placed beneath muscle; strap muscles approximated; platysma by continuous absorbable suture; skin by subcuticular sutures
Important: For carcinoma total thyroidectomy - start with the lobe containing lesion; if RLN injured on that side, abort with hemithyroidectomy rather than proceeding to total

POST-OPERATIVE COMPLICATIONS OF THYROIDECTOMY

ComplicationKey Points
HemorrhageTension hematoma = emergency (tracheal compression); sudden swelling + breathlessness in early post-op period
Respiratory obstructionUsually due to laryngeal edema; causes = tension hematoma, trauma to larynx during intubation, tracheomalacia
TracheomalaciaAfter huge long-standing goitre; tracheal rings collapse after surgery; treat with endotracheal intubation/tracheostomy for 2-3 days
RLN injuryUnilateral = asymptomatic or voice change; Bilateral = median/paramedian vocal cords, non-occlusive cough + dyspnea; mostly temporary, recovers in 3 weeks - 3 months
HypocalcemiaDue to removal/infarction of parathyroids; Chvostek's + Trousseau's sign; develops 24-48 hours post-op; treat with calcium supplementation
Thyrotoxic Crisis (Storm)Acute exacerbation of hyperthyroidism; occurs when patient NOT adequately prepared pre-op; huge thyroxine release from damaged follicles
Thyroid insufficiencyAfter total thyroidectomy; prevent with lifelong thyroxine 150mcg/day
Recurrence of goitreAfter subtotal/lobectomy; prevent with suppressive dose thyroxine 200mcg/day

Management of Neck Swelling + Dyspnea after Thyroidectomy:

  1. Immediately look for airway obstruction signs
  2. Inform senior
  3. Release skin stitches + deep stitches to relieve compression
  4. May need cricothyroidotomy to secure airway before shifting to OT
  5. Avoid endotracheal intubation
  6. In OT: evacuate hematoma, ligate bleeding vessel, wash with normal saline, place drain
  7. Transfuse blood if necessary

Thyrotoxic Crisis (Storm) Treatment:

  1. IV fluids to correct dehydration
  2. IV hydrocortisone
  3. Oxygen inhalation
  4. Digoxin for uncontrolled atrial fibrillation
  5. Cooling with ice packs
  6. Specific:
    • Carbimazole 10-20mg 6-hourly
    • Lugol's iodine 10 drops 8-hourly
    • Propranolol 1-2mg IV or 40mg orally 6-hourly

🦷 PARATHYROID GLANDS (pp. 291-293)


ANATOMY

  • Khaki colored, oval in shape
  • Size: up to 6mm length; weight: 30-50mg each; usually 4 in number
  • Superior parathyroids: Level of cricoid cartilage, posterior to RLN
  • Inferior parathyroids: Lower pole of thyroid, anterior to RLN
  • Blood supply from inferior thyroid artery (branches guide their position)
Histology: Chief cells (PTH-secreting) + Oxyphil cells + Stromal connective tissue & fat

FUNCTIONS OF PTH

Acts on 3 target organs: Bone, Kidney, Gut
  • Bone: Stimulates osteoclasts β†’ releases calcium + phosphate into circulation
  • Kidney: Limits calcium excretion at distal convoluted tubule (via active transport); inhibits phosphate reabsorption from proximal convoluted tubule
  • Gut: Causes absorption of calcium (via Vit D activation)
  • PTH secretion stimulated by low calcium in circulation
  • Half-life of PTH = 2 to 4 minutes

HYPERPARATHYROIDISM

Primary HPT - Causes:

  • Adenoma: 85% (usually single; 80% involve single gland; chief cells predominate)
  • Hyperplasia: 13% (involves all 4 glands; >70mg)
  • Carcinoma: 1-2%
  • Can occur in MEN-1 and MEN-2A

Clinical Features - Mnemonic:

"Kidney stones, Broken bones, Abdominal groans and Psychiatric moans, Fatigue overtones"
  • Kidney stones: Hypercalcemia β†’ renal calculi
  • Broken bones: ↑osteoclastic activity β†’ pathological fractures, osteopenia, osteoporosis, osteitis fibrosa cystica
  • Abdominal groans: Constipation, indigestion, nausea, vomiting, peptic ulcers, acute pancreatitis
  • Psychiatric moans: CNS effects
  • Fatigue overtones: Lethargy, fatigue, depression, memory loss, psychosis, ataxia, delirium, coma
German description: "Stein-, Bein- und Magenpein" = stone, bone, stomach-pain

Diagnosis of Primary HPT:

  • Hypercalcemia + raised PTH
  • Hypophosphatemia + elevated urinary calcium excretion
  • Alkaline phosphatase (skeletal) may be raised (bone resorption)
Treatment = Surgery (only curative therapy)
Indications for surgery in asymptomatic HPT (2002 consensus):
  • Serum calcium >1.0 mg/dl above upper limit of normal
  • 24-hour urinary calcium >400mg
  • Creatinine clearance reduced by 30%
  • Bone mineral density t-score ≀ -2.5 at any site

Pre-operative Localization:

  • Diagnosis of primary HPT is biochemical; localization is for surgical planning only
  • Ultrasound + Technetium-99m sestamibi (MIBI) scan can localize 80% of adenomas
  • Adenoma usually involves single gland (80%); hyperplasia involves all 4 glands

Surgical Approach:

  • Single adenoma: Remove single gland; intraoperative PTH measurement (if PTH falls by 50% or more at 10 minutes after removal β†’ source of excess PTH removed β†’ abandon further exploration)
  • All 4 glands hyperactive (hyperplasia): Remove all 4 glands + autotransplant 50mg of parathyroid tissue into brachioradialis muscle to avoid future hypoparathyroidism

Complications of Surgery:

  • Failure to achieve cure (5%)
  • RLN damage
  • Hypoparathyroidism
  • Recurrent hyperparathyroidism / severe hypercalcemia

Medical Treatment (mild/asymptomatic cases):

  • General measures: hydration, decrease dietary calcium, stop thiazide/lithium
  • Bisphosphonates + estrogen therapy
  • Calcium receptor agonist (cinacalcet)
  • Parathyroid crisis (severe hypercalcemia >3.5mmol/L or 14mg/dl): IV saline + bisphosphonate therapy; admit to ICU

SECONDARY & TERTIARY HYPERPARATHYROIDISM

  • Secondary HPT: Over-secretion of PTH in response to low plasma calcium (usually due to chronic renal failure or GI malabsorption)
    • Managed initially by 1-alpha-hydroxyvitamin D3 (alfacalcidol) to increase calcium absorption
    • Renal transplantation usually cures it
  • Tertiary HPT: Excessive PTH secretion in secondary HPT becomes autonomous; may occur after renal transplantation
    • Treatment: Total parathyroidectomy + calcium & vitamin D replacement; OR subtotal parathyroidectomy leaving half-equivalent of a normal gland in situ; OR autotransplantation of parathyroid tissue into arm muscle

HYPOPARATHYROIDISM

  • Most common cause = thyroid surgery (particularly total thyroidectomy with neck dissection)
  • Transient hypocalcemia common (ischemia of parathyroids); permanent hypoparathyroidism is rare
  • Also occurs after total parathyroid surgery
  • Parathyroids may be congenitally absent in DiGeorge syndrome
Symptoms & Signs (due to hypocalcemia):
  • Paraesthesia ("pins and needles") in hands/feet
  • Muscle cramps + spasms (tetany) β†’ bunching/flexion of fingers and toes
  • Respiratory obstruction with stridor (laryngeal muscle spasm - can be fatal)
  • Chvostek's sign: Contraction of facial muscles by tapping on facial nerve anterior to ear
  • Trousseau's sign: Carpopedal spasm elicited by occluding blood flow to forearm with BP cuff for 2-3 minutes
Diagnosis: Low ionized calcium + low PTH + ECG shows lengthened Q-T interval
Treatment of Acute Hypoparathyroidism:
  • IV calcium gluconate (20ml of 10% solution diluted in 100ml saline) 4-hourly until calcium levels rise
  • Oral calcium supplementation + Vitamin D (calcitriol) according to serial blood calcium levels

PARATHYROID CARCINOMA

  • Rare; 1% of patients with hyperparathyroidism
  • 50% present with palpable neck mass
  • Diagnosis: Histological findings of vascular or capsular invasion, lymph node or distant metastasis
  • Treatment: Treat severe hypercalcemia medically first (rehydration + IV bisphosphonates); then radical excision of gland + lymphadenectomy + ipsilateral lobectomy of thyroid gland

Key High-Yield Mnemonics:
  • FNAC cannot distinguish follicular adenoma from carcinoma (needs excision)
  • Pemberton's sign = retrosternal goitre (engorged veins on raising arm above head)
  • RET proto-oncogene mutation = MTC (familial, MEN2A, MEN2B)
  • Phaeochromocytoma operated FIRST before thyroidectomy in MEN-2A
  • Kidney stones, Broken bones, Abdominal groans, Psychiatric moans = Primary HPT
  • Chvostek's = tap facial nerve β†’ face twitches; Trousseau's = BP cuff β†’ carpopedal spasm
  • Sestamibi scan localizes 80% of parathyroid adenomas
  • PTH falls >50% at 10 min post-removal = successful parathyroidectomy
  • DiGeorge syndrome = congenitally absent parathyroids
This is a shared conversation. Sign in to Orris to start your own chat.